NCT04256330 Cardiometabolic Health and Inflammatory Resolution
| NCT ID | NCT04256330 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Volunteers |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-01-23 |
| Primary Completion | 2026-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The aim of this study is to determine how inflammatory resolution impacts cardiometabolic health and disease in subjects that are either lean (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2) or obese (\>30.0 kg/m2).
Eligibility Criteria
Inclusion Criteria: * Informed signed consent has been obtained from the volunteer. * The volunteer has a BMI greater than 18.5 kg/m2 Exclusion Criteria: * The study staff contacting a potential participant perceives that the individual has difficulty understanding the information. * An MD determines that the individual is on too many medications to participate * The individual takes a medication that is approved by the MD, but he/she is not willing or not able to wait with any potential morning medication until after their fasted blood-draw. * The individual is younger than 18 years (relevant for the FAINT-1 and FAINT-2 cohorts) * The individual states that they have increased bleeding tendency or are using anti-coagulant (blood thinning) medication. * The individual has some form of chronic inflammation. * The individual regularly uses medication that affects inflammatory resolution (e.g., low-dose aspirin). * The individual uses immunosuppressive drugs (eg, methotrexate). * The indi